The tweet was deleted by the author.
But we saved everything 🙂.
Nautilus Biotechnology has published the latest edition of its "Proteomics and neuroscience" eBook, showcasing how its Voyager Platform is being applied to advance research on tau proteoforms in Alzheimer disease and related dementias.
The new volume details innovative insights and experimental techniques that allow scientists to investigate the complexities of neurodegenerative disorders more effectively. The eBook aims to serve as a resource for researchers looking to deepen their understanding of the molecular mechanisms behind these challenging conditions.
Earlier this year, Nautilus Biotechnology presented advances in single molecule proteomics using its Voyager platform at ASMS, with company experts available for discussions on site (link). The company also unveiled research focused on high-accuracy quantification of tau proteoforms at ASMS2026 (link). These efforts align with Nautilus's ongoing work to support proteomics and neuroscience research.